Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published July 11, 2014

Jubilant Recalls Losartan/HCTZ Tablets Due to Steel Contamination

Jubilant Cadista recalls 90-count bottles of Losartan Potassium and Hydrochlorothiazide tablets due to stainless steel fragments. Check your lot number.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-1500-2014DrugJubilant Cadista ›
Take action

Contact the company

Recalling firmJubilant Cadista Pharmaceuticals Inc.207 Kiley Dr · Salisbury, MD 21801-2249
✎ GovInfoNow plain-language explainer

Jubilant Cadista Pharmaceuticals Inc. is recalling specific lots of Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg because they may contain dark blemishes identified as stainless steel. The recall affects 9,358 bottles distributed nationwide and in Puerto Rico. The record does not specify the remedy or current status for consumers. Read more at govinfonow.com/recall/45953-jubilant-cadista-pharmaceuticals-inc-recalls-losartan-potassium-and-hydrochlorothiazide-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/45953-jubilant-cadista-pharmaceuticals-inc-recalls-losartan-potassium-and-hydrochlorothiazide-tablets · Updated October 12, 2026 · FDA enforcement record: FDA #D-1500-2014

Cite this page

“Jubilant Recalls Losartan/HCTZ Tablets Due to Steel Contamination.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45953-jubilant-cadista-pharmaceuticals-inc-recalls-losartan-potassium-and-hydrochlorothiazide-tablets. Based on FDA recall #D-1500-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1500-2014%22&limit=1).

Jubilant Cadista Pharmaceuticals Inc. voluntarily recalled Losartan Potassium and Hydrochlorothiazide Tablets due to the presence of stainless steel fragments, according to the FDA on July 11, 2014.

How to tell if you have it

  • Brand: Jubilant Cadista
  • Product: Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg
  • Packaging: 90-tablets per bottle
  • NDC: 59746-339-90
  • Lot Code: 14P0292
  • Expiration Date: 04/2016

The hazard

The tablets may contain dark blemishes identified as stainless steel, posing a foreign substance hazard.

Context

GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has had 24 other recalls on record since February 11, 2013. Other recent recalls of similar products include JB Chemicals Recalls Cetirizine Tablets Due to Cross-Contamination (June 24, 2026), Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall: Metallic Particles Hazard (May 28, 2026), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall: N-Nitroso Impurity Risk (January 21, 2026).

How to tell if you have this one

Check your bottle for the following details: NDC # 59746-339-90, Lot #14P0292, Expiration date 04/2016. The product is Losartan Potassium and Hydrochlorothiazide Tablets, USP 100 mg/25 mg, in 90-tablet bottles. It was manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD.

  • Brand
    Jubilant Cadista
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if your bottle matches NDC # 59746-339-90 and Lot #14P0292 with an expiration date of 04/2016.

  2. Contact your pharmacist

    Speak with your healthcare provider or pharmacist to determine the appropriate next steps for your prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Jul 11, 201412. FDA classified it Class II: Jul 31, 201423. Published in FDA’s Enforcement Report: Aug 6, 201434. FDA terminated the recall: Sep 15, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026K.C. Pharmaceuticals, Inc. recalls Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ (15 mL); a) LEADER, DISTRIBUTED BY CARDINAL HEALTH, DUBLIN, OHIO
Leader / TopCare / Crocodile Tears · September 11, 2026Amneal Pharmaceuticals, LLC recalls Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater,
Amneal Pharmaceuticals · September 8, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1500-2014 (July 11, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1500-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA